Vaccine Scheduler

Influenza: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Months		Years
	6	23	2	3	5	6	7	12	17	18	45	50	55	59	60	≥ 65
Austria	IIV4/LAIV										IIV4/aIIV4/QIV-HD¹

Belgium	IIV4															IIV4/QIV-HD²

Bulgaria	IIV3/IIV4/LAIV³										IIV3/IIV4⁴

Croatia	IIV4⁵															IIV4

Cyprus	IIV4⁶															aIIV4

Czechia	IIV4/LAIV⁷											IIV4/QIV-HD⁸

Denmark																IIV4⁹

Estonia	IIV4¹⁰														IIV4

Finland	IIV4/LAIV¹¹															IIV4

France			IIV4													IIV4

Germany	IIV4¹²														IIV4/QIV-HD¹³

Greece	IIV3¹⁴														IIV4/aIIV4/QIV-HD¹⁵

Hungary	IIV4¹⁶														IIV3

Iceland	IIV4														IIV4¹⁷

Ireland	IIV4/LAIV¹⁸														IIV4¹⁹

Italy	LAIV/IIV3/cIIV3²⁰														aIIV3/TIV-HD/IIV3

Latvia	IIV4/LAIV		IIV4/LAIV²¹												QIV-HD

Liechtenstein	IIV4²²										IIV4²³

Lithuania	IIV4²⁴															IIV4²⁵

Luxembourg																IIV4

Malta	IIV4												IIV4

Netherlands															IIV4²⁶

Norway																IIV3/aIIV3

Poland	IIV4										IIV4/QIV-HD²⁷

Portugal															IIV4/QIV-HD²⁸

Romania	IIV3/IIV4/LAIV										IIV3/IIV4/QIV-HD²⁹

Slovakia	IIV4/LAIV³⁰													IIV4

Slovenia	IIV4³¹															IIV4

Spain	IIV4/cIIV4/LAIV														IIV4/aIIV4/cIIV4/QIV-HD

Sweden	IIV4/LAIV															IIV4

Footnotes:

QIV-HD (not funded). More information: https://impfen.gv.at/impfungen/influenza
Partially funded. In part of the country (Flanders), the vaccine is provided and administered entirely free of charge for residents of nursing homes.
Inactivated vaccines are recommended for children over 6 months of age. LAIV is recommended for children over 24 months of age. Vaccines are not funded but vaccine administration is funded by the national health insurance.
Inactivated vaccines are recommended for all people over 18 years of age. Vaccines are not funded but vaccine administration is funded by the national health insurance only for insured. For people over 65 years of age vaccines and administration are free according to the national programme. Free of charge for those aged 65 years and above until the 2023–26 influenza season
Children and adolescents that are not at risk can get the influenza vaccine from six months old but it is not funded. Vaccination is recommended and funded by Croatian Health Insurance for all children at risk.
The vaccine can be given as a specific recommendation for individuals six months to 17 years old with a chronic medical condition. https://www.gov.cy/moh/en/national-vaccination-advisory-committee/
Universal recommendation is given for all age groups but children from six months to five years old belong to the high-risk group. For more information: https://vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-k-ockovani-proti-chripce-4
For individuals below 65 years old, funding is only for specified patients with risk conditions on treatment and is funded for IIV4. QIV-HD is funded for whole population over 65 years old. More information: https://vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-k-ockovani-proti-chripce-4
In children, there is no general recommendation, only for certain risk groups.
Vaccination is free for the following groups: residents of welfare institutions, people aged 60 years and older, children aged six months to seven years old, pregnant women, children and adolescents 7–17 years old who have an increased risk of becoming seriously ill due to their health condition (heart and blood vessel diseases, oncological diseases, immunodeficiency, diabetes and obstructive lung disease).
more information: https://thl.fi/en/topics/infectious-diseases-and-vaccinations/information-about-vaccinations/vaccination-programme-for-children-and-adults
Children/adolescence between the age of 6 month and 17 years with one or more medical condition or underlying disease, are recommended to receive seasonal influenza vaccination. Medical conditions or underlying diseases to consider are: -Chronic diseases of the respiratory tract, including asthma and chronic obstructive pulmonary disease (COPD) -Chronic cardiovascular, liver and kidney disease -Diabetes mellitus and other metabolic diseases -Chronic neurological diseases, e. g., multiple sclerosis with relapses triggered by infections -Congenital or acquired immunodeficiency -HIV infection More information is available at: https://www.rki.de/DE/Aktuelles/Publikationen/Epidemiologisches-Bulletin/2024/04_24.pdf?__blob=publicationFile&v=4
For more information: https://www.rki.de/EN/Topics/Infectious-diseases/Immunisation/STIKO/STIKO-recommendations/recommendations_content.html
Since 2024 flu vaccination is recommended to all children between 6 months -5 years of age. In addition, Greece has recommendations for children and adolescents belonging to high-risk groups. Source: https://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/emboliasmoi/ethniko-programma-emboliasmwn-epe-paidiwn-kai-efhbwn
QIV-HD and aIIV4 recommended in adults aged =65 years.
Hungary’s recommendation is for children 6–35 months old with chronic pulmonary, cardiovascular, renal or hepatic disease, metabolic disorders or immunosuppression due to disease or treatment
Annual vaccination (IIV4 introduced in 2020 to replace IIV3)
LAIV is recommended and funded for 24 months to <18 years. IIV4 was also recommended and funded for children aged >6 months to 17 years with medical conditions in 2024-25 influenza season.
The national influenza programme was funded for those aged 60 years in 2024-25 influenza season. Influenza vaccine was also recommended for those aged 50-59 but not funded for vaccine and its administration.
Vaccination is offered free of charge to all children from six months to six years old. From six months onwards, vaccination is offered free of charge to all people with chronic medical conditions
The vaccine is recommended for children and adolescents aged 24 months to 17 years with chronic lung or cardiovascular diseases, chronic metabolic or kidney conditions or immunodeficiency, as well as those receiving immunosuppressive therapy or long-term acetylsalicylic acid therapy. https://www.spkc.gov.lv/lv/vakcinacija#valsts-apmaksata-vakcinacija-pret-gripu
For 6 months to 8 years, vaccination is not recommended for healthy children but is recommended for premature babies (born before gestational week 33 (e.g. <32 weeks and seven days of pregnancy) or with a birth weight of less than 1 500g) from the age of six months and for the first two winters after birth. For 6 months to 18 years, vaccination is recommended for children and adolescents with chronic medical conditions.
For individuals aged >=18 years, the recommended influenza vaccines are Vaxigrip Tetra®, Fluarix Tetra®, Influvac Tetra®, and Flucelvax Tetra®. The same vaccines (Vaxigrip Tetra®, Fluarix Tetra®, Influvac Tetra®, Flucelvax Tetra®) are also recommended for those aged >=50, >=55, >=59, and >=60 years. For individuals aged >=65 years, the recommended vaccine is Efluelda®.
Universal recommendation for all age groups. Funding for risk groups: 24 months to seven years old (included in the Lithuanian immunisation schedule from 12 February 2024, starting with the 2024–2025 season) and from six months to under18 years old with chronic medical conditions.
Universal recommendation for all age groups. Funding only for those over 65 years old (included in the immunisation schedule).
https://www.rivm.nl/en/flu-and-flu-jab
The vaccine and its administration are partially funded (50%). QIV-HD in adults aged 60 years and above. https://szczepienia.pzh.gov.pl/szczepionki/grypa/?strona=9#jak-refundowane-sa-szczepionki-przeciw-grypie-w-sezonie-2024/2025
QIV-HD is funded for people aged 85 years and older. More information: https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-072024-de-04092024-atualizada-a-07032025-campanha-de-vacinacao-sazonal-contra-a-gripe-outono-inverno-2024-2025-.aspx
For adults aged 45–65 years without chronic medical conditions, the influenza vaccines are 50% reimbursed. For those aged 65 years and above the vaccine is fully reimbursed.
Vaccination against influenza is supported by the legislation for children 6 months – 12 years, individuals with specified chronic medical conditions, older adults aged 59 years and above and people accommodated in long-term facilities. However, the vaccination is generally recommended and fully funded to the whole population in every influenza season.
Vaccination is also recommended for the specific risk groups (children aged 6–23 months, pregnant women, those with chronic medical conditions, older adults aged 65 years and above).